Making sure healthcare innovation is backed by solid clinical evidence and meets the regulatory bar it needs to actually reach patients.
I am a clinical researcher and regulatory affairs professional working at the intersection of clinical validation and healthcare innovation. My path runs from bench to bedside to boardroom: laboratory research, a cardiology internship in a German hospital, international clinical trial monitoring and, now, clinical and regulatory strategy for digital health.
At Mential I work on clinical validation, regulatory compliance (EU MDR, GDPR) and European funding for a digital health company whose AI engine turns text, voice and questionnaire data into FHIR-coded longitudinal clinical markers.
Before that, at CERC, I coordinated clinical trials across more than 35 hospitals in Spain, the Czech Republic, Malaysia, the UAE and the UK — site initiation visits, monitoring, source data verification and query resolution under GCP/ICH.
Earlier, I conducted research at the CSIC on tumor microenvironment biology, studying the role of irradiated fibroblasts, PDGF signaling, endothelial cell proliferation and tubulogenesis. I also completed a clinical cardiology rotation in Germany, with exposure to angiography, angioplasty, TEE and advanced ECG interpretation.
Beyond the lab and the clinic, I am building BioInsight — a science communication platform translating complex biomedical research into clear, rigorous content — and exploring how AI tools and structured knowledge systems can amplify scientific thinking.
Validation protocols, EU MDR and GDPR for an AI digital health product
Oncology research, tumor microenvironment, cellular biology
Internship at Klinik Vincentinum, Augsburg — cardiology procedures
BioInsight: 94 published articles, 29 biomedical areas covered
International hospital sites coordinated as CRA
Scientific papers processed and analyzed in BioInsight
Published science communication articles
From molecular biology laboratories to international clinical trial networks — a career defined by scientific rigor and cross-disciplinary range.
Technical & analytical skills
Languages
BioInsight is a biomedical science communication platform built to close the gap between cutting-edge research and public understanding. Each article translates peer-reviewed literature into rigorous, accessible content — without sacrificing scientific depth.
Covering oncology, neuroscience, cardiology, regenerative medicine, AI in health, and more — BioInsight builds a documented voice at the intersection of research, innovation and society.
Published articles on active biomedical topics
Clinical and scientific areas covered
Scientific papers reviewed and indexed
Platform launched, new article every day
Scientific areas
This website was built with Claude, Nano Banana and Klint — a direct demonstration that AI tools are not just subjects to write about, but instruments to build with.
Beyond this project, I have developed a structured knowledge system combining Claude and Obsidian to organize scientific literature, generate connections between papers, automate research workflows and accelerate my thinking.
The system allows me to process, link and surface insights from 146+ scientific papers, manage BioInsight's content pipeline, and build projects like NewroPlay — at a pace and depth that would not otherwise be possible.
The goal is not to delegate reasoning to AI. It is to amplify the capacity to learn, research, write and build — keeping scientific judgment firmly human.
Active tools & systems
Core reasoning engine for research, writing and project building
Linked knowledge base: papers, notes, MOCs and second brain architecture
AI-assisted interface used in this website's design process
Design and visual workflow support for digital projects
Data analysis, clinical data cleaning and statistical exploration
An early-stage digital health concept exploring AI-assisted neurorehabilitation and interactive cognitive support. NewroPlay investigates how interactive, AI-driven tools can support patients with neurological conditions — including stroke survivors — through structured cognitive and motor rehabilitation experiences.
Rooted in neuroscience, clinical evidence and human-centered design — details remain protected while the concept develops.
Interested in clinical research collaborations, BioInsight contributions, or just a conversation about science and innovation — reach out.